These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7637742)

  • 1. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts.
    Baldassano V; Dunn JP; Feinberg J; Jabs DA
    N Engl J Med; 1995 Sep; 333(10):670. PubMed ID: 7637742
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of cytomegalovirus retinitis in Tanzanians with low CD4 levels.
    Nirwoth JP; Hall AB; Lewallen S
    Br J Ophthalmol; 2011 Apr; 95(4):460-2. PubMed ID: 21106992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis.
    Jacobson MA; Bredt BM
    J Infect Dis; 2002 Dec; 186(11):1701-2; author reply 1702-3. PubMed ID: 12447752
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR; Baldassano VF; Whitcup SM
    Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.
    Jacobson MA; Schrier R; McCune JM; Torriani FJ; Holland GN; O'Donnell JJ; Freeman WR; Bredt BM
    J Infect Dis; 2001 May; 183(9):1399-404. PubMed ID: 11294673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major blinding complication of acquired immune deficiency syndrome (AIDS).
    Akduman L; Arribas JR; Del Priore LV; Kaplan HJ; Powderly WG
    Retina; 1997; 17(2):167-8. PubMed ID: 9143050
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-HIV drugs allow immune system to rebound, fight CMV.
    Optom Vis Sci; 2000 Jan; 77(1):3. PubMed ID: 10654853
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytomegalovirus retinitis in HIV-infected patients with elevated CD4+ counts.
    Fekrat S; Dunn JP; Lee D; Miller T; Jabs DA
    Arch Ophthalmol; 1995 Jan; 113(1):18. PubMed ID: 7826288
    [No Abstract]   [Full Text] [Related]  

  • 11. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stein DS
    Lancet; 1997 Aug; 350(9077):589-90. PubMed ID: 9284796
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
    Hsieh SM; Pan SC; Hung CC; Tsai HC; Chen MY; Chang SC
    J Infect Dis; 2001 Dec; 184(11):1386-91. PubMed ID: 11709780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T lymphocytes and cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Lowder CY; Butler CP; Dodds EM; Secic M; Recillas-Gispert C
    Am J Ophthalmol; 1995 Sep; 120(3):283-90. PubMed ID: 7661199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution.
    Johnson SC; Benson CA; Johnson DW; Weinberg A
    Clin Infect Dis; 2001 Mar; 32(5):815-9. PubMed ID: 11229851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse of CMV retinitis in an AIDS patient with high CD4 counts.
    Petit N; Zandotti C; Riss JM; Frippiat F; Moulin JF; Gastaut JA
    J Antimicrob Chemother; 1998 Jun; 41(6):666-7. PubMed ID: 9687110
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for cytomegalovirus retinitis at an AIDS clinic.
    Carmichael TR; Sher R
    S Afr Med J; 2002 Jun; 92(6):445-7. PubMed ID: 12146128
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
    Banker AS; Patel A
    Indian J Ophthalmol; 2002 Mar; 50(1):29-33. PubMed ID: 12090084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T lymphocytes and cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Pakola SJ; Nichols CW
    Am J Ophthalmol; 1996 Apr; 121(4):455-6. PubMed ID: 8604747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.